Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2026-04-18 @ 7:13 PM
Study NCT ID:
NCT05963334
Status:
COMPLETED
Last Update Posted:
2023-07-27
First Post:
2023-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer
Sponsor:
Cairo University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Epithelial Ovarian Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Carboplatin induced side effects | View |
| None | Patient safety | View |
| None | Acute and chronic kidney injury | View |
| None | Anemia, neutropenia and thrombocytopenia | View |
| None | Advanced epithelia ovarian cancer | View |
| None | Improved patient toleration | View |
| None | Patient counselling and education | View |
| None | Routine laboratory tests and tumor markers comparison | View |
| None | Additional biomarkers | View |
| None | Cystatin-C (Cys-C) | View |
| None | Neutrophil gelatinase associated lipocalin (NGAL) | View |
| None | Interleukin-18 (IL-18) | View |
| None | Hepcidin (HEPC) | View |
| None | Kidney injury marker-1 (KIM-1) | View |
| None | Quality of life | View |
| None | Health related quality of life outcomes | View |
| None | Progression free survival | View |
| None | Palliative care | View |
| None | Chemotherapy, surgery and non-pharmacological treatment of ovarian cancer | View |
| None | Functional assessment of cancer therapy for ovarian cancer (FACT-O) | View |
| None | Functional assessment of cancer therapy/gynecologic oncology group/neurotoxicity (FACT-GOG/NTX) | View |